PMC3513729_01
Axial T2-weighted MR image at the level of bilateral hip joint showing posterior displacement of the epiphysis of femoral head on left side (arrow).
CRIM.ENDOCRINOLOGY2012-567060.001.jpg
PMC3513729_01_CRIM.ENDOCRINOLOGY2012-567060.001.jpg
fig1
X-ray and subsequent MRI confirmed a slipped capital femoral epiphysis (SCFE) of the left hip (Figure 1).
Axial ultrasound images taken just above the level of thyroid isthmus showing a well-defined, heterogeneous, predominantly hypoechoic round lesion in the right lobe of thyroid. Small echogenicities within the lesion were noted suggestive of microcalcification (black arrows). Another larger heterogeneous solid lesion is seen in the left lobe of thyroid.
CRIM.ENDOCRINOLOGY2012-567060.002.jpg
PMC3513729_01_CRIM.ENDOCRINOLOGY2012-567060.002.jpg
fig2
Ultrasonography of the anterior neck showed well-defined, heterogeneous, predominantly hypoechoic round lesions in both the lobes of thyroid measuring 22.4 x 17.6 mm on left side and 10 x 6.9 mm on the right with tiny echogenic foci consistent with calcification within the lesion (Figure 2).
Ultrasound of abdomen showing heterogeneous lesions at the upper poles of both kidneys suggestive of bilateral adrenal masses.
CRIM.ENDOCRINOLOGY2012-567060.003.jpg
PMC3513729_01_CRIM.ENDOCRINOLOGY2012-567060.003.jpg
fig3
Ultrasound screening of abdomen showed heterogeneous hypoechoic lesions at the upper poles of bilateral kidneys consistent with bilateral adrenal masses (Figure 3).
Axial contrast enhanced CT images of abdomen taken at the level of adrenals showing large round heterogeneous lesions in bilateral adrenals with left adrenal lesion showing central necrosis and fluid-fluid level. Central hypodense nonenhancing area is suggestive of necrosis with intense peripheral enhancement.
CRIM.ENDOCRINOLOGY2012-567060.004.jpg
PMC3513729_01_CRIM.ENDOCRINOLOGY2012-567060.004.jpg
fig4
Abdominal computed tomography (CT) scan showed large, bilateral, heterogeneous suprarenal lesions with central necrosis and intense peripheral postcontrast enhancement consistent with pheochromocytomas (Figure 4).